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Abstract
Background: Acetaminophen overdose is the most common cause of acute liver failure (ALF).
Our objective was to develop coding algorithms using administrative data for identifying patients
with acetaminophen overdose and hepatic complications.
Methods: Patients hospitalized for acetaminophen overdose were identified using population-
based administrative data (1995–2004). Coding algorithms for acetaminophen overdose,
hepatotoxicity (alanine aminotransferase >1,000 U/L) and ALF (encephalopathy and international
normalized ratio >1.5) were derived using chart abstraction data as the reference and logistic
regression analyses.
Results: Of 1,776 potential acetaminophen overdose cases, the charts of 181 patients were
reviewed; 139 (77%) had confirmed acetaminophen overdose. An algorithm including codes 965.4
(ICD-9-CM) and T39.1 (ICD-10) was highly accurate (sensitivity 90% [95% confidence interval 84–
94%], specificity 83% [69–93%], positive predictive value 95% [89–98%], negative predictive value
71% [57–83%], c-statistic 0.87 [0.80–0.93]). Algorithms for hepatotoxicity (including codes for
hepatic necrosis, toxic hepatitis and encephalopathy) and ALF (hepatic necrosis and
encephalopathy) were also highly predictive (c-statistics = 0.88). The accuracy of the algorithms
was not affected by age, gender, or ICD coding system, but the acetaminophen overdose algorithm
varied between hospitals (c-statistics 0.84–0.98; P = 0.003).
Conclusion:  Administrative databases can be used to identify patients with acetaminophen
overdose and hepatic complications. If externally validated, these algorithms will facilitate
investigations of the epidemiology and outcomes of acetaminophen overdose.
Background
Administrative databases are ubiquitous and used in all
areas of health care financing and delivery. Health care
providers, policy-makers, and payers use administrative
data for reimbursement, budgetary planning, monitoring
clinical activities, measuring the quality of care, and
health services research [1,2]. The critical variable in all of
these applications is the patient diagnosis, typically
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recorded using the International Classification of Diseases
(ICD) Ninth Revision, Clinical Modification (ICD-9-CM) [3]
or Tenth Revision (ICD-10) [4] coding systems. This data
can be used to identify specific patient cohorts and assess
their clinical outcomes with risk adjustment in many
cases. Clearly, the accuracy and completeness of diagnoses
within administrative databases is paramount to reaching
valid conclusions [5]. As such, the validation of adminis-
trative data has been the focus of numerous investiga-
tions, typically via audits of medical records. The results of
validation studies have varied depending on the type of
administrative data (eg. inpatient vs. outpatient and diag-
nostic vs. procedural), specific disease area and codes used
for case identification, and disease severity [5].
To our knowledge, the accuracy of administrative data for
the identification of acetaminophen overdose and hepa-
totoxicity has not been examined. This is surprising con-
sidering the magnitude of the problem – acetaminophen
overdose is the most common cause of self-deliberate poi-
soning [6] and acute liver failure (ALF) [7-9]. Recent data
from the U.S. ALF Study Group identified acetaminophen
as the etiology in approximately 50% of cases [8]. Moreo-
ver, numerous studies have examined the epidemiology
and outcomes of acetaminophen overdose using adminis-
trative data without confirming its accuracy [10-13]. For
example, Bateman et al. used a nationwide hospital dis-
charge database to demonstrate a reduction in admissions
for acetaminophen overdose in Scotland between 1997
and 1999 [10]. This decrease was attributed to package
size legislation introduced in the United Kingdom (U.K.)
in 1998 due to rising rates of acetaminophen overdose
[14-17]. Using similar methodology, Prior et al. failed to
detect an impact of increased acetaminophen availability
on rates of hospitalization for overdose or acute liver tox-
icity in Canada [11]. To draw valid conclusions from this
type of study, the accuracy of these diagnoses must be con-
firmed.
Therefore, the objectives of our study were: 1) to deter-
mine the validity of ICD-9-CM  and  ICD-10  diagnostic
codes for acetaminophen overdose and hepatotoxicity
using a population-based, hospitalization database; and
2) to derive accurate coding algorithms for the identifica-
tion of these diagnoses for use in future studies employing
administrative data.
Methods
Study setting and data source
This administrative database and chart abstraction study
was conducted in the Calgary Health Region (CHR), one
of the largest fully integrated, publicly funded health care
systems in Canada. The CHR provides virtually all medi-
cal and surgical care to approximately 1.2 million resi-
dents of Calgary and surrounding communities in
southern Alberta. Included within the region are three
large, adult, acute-care hospitals in Calgary. Study subjects
were identified using regional administrative data that
contains a detailed record of all hospital admissions
including diagnostic and procedural information. In this
database, diagnoses are coded by trained health records
nosologists according to the International Classification of
Disease, Ninth Revision, Clinical Modification (ICD-9-CM)
[3] for fiscal years 1995–2001 and ICD-10 [4] for 2002–
2004 (ICD-10  codes shown in italics throughout this
manuscript). The database has been used to examine the
epidemiology,[18,19] outcomes, [20-22] and coding
accuracy [23-26] of a variety of medical conditions. The
cohort of potential acetaminophen overdose cases was
identified by searching for appropriate ICD-9-CM  and
ICD-10 codes in either the primary or 15 secondary diag-
nosis fields (Table 1). Our preliminary search was
Table 1: ICD-9-CM and ICD-10 codes used to identify potential cases of acetaminophen overdose
Diagnostic Codes Definition
ICD-9-CM
965.4 † Poisoning by aromatic analgesics including acetaminophen
E850.4 Accidental poisoning by aromatic analgesics including acetaminophen
E935.4 Adverse effects of therapeutic use of aromatic analgesics including acetaminophen
E950.0 * Suicide and self-inflicted poisoning by analgesics, antipyretics and antirheumatics
ICD-10
T39.1 † Poisoning by 4-aminophenol derivatives
X40 * Accidental poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics including acetaminophen
Y45.5 Adverse effects of therapeutic use of 4-aminophenol derivatives
X60 * Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics including 
acetaminophen
Y10 * Poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics, including acetaminophen, of 
undetermined intent
† Principal acetaminophen overdose codes.
* Non-specific diagnostic codes.BMC Health Services Research 2007, 7:159 http://www.biomedcentral.com/1472-6963/7/159
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designed to maximize sensitivity, thus some of the codes
are non-specific. For example, several codes (herein
referred to as 'non-specific codes') may include overdoses
due to other medications such as salicylates and nonster-
oidal anti-inflammatory drugs (NSAIDs) (E950.0, X40,
X60, Y10).
Validation study
The validation component of the study was designed to
develop coding algorithms for the diagnosis of acetami-
nophen overdose, hepatotoxicity, and ALF. Since liver
injury occurs in only a small minority of overdose
patients, [27-31] we intentionally over-sampled this
group using a highly sensitive algorithm to identify the
cohort for chart review. This algorithm included the fol-
lowing diagnostic codes: hepatic necrosis (570, K71.1),
toxic hepatitis (573.3, K71.2, K71.6, K71.9), hepatic
encephalopathy (572.2, K72.0, K72.9), hepatorenal syn-
drome (572.4, K76.7), jaundice (782.4, R17), coagulopa-
thy (286.7, D68.4, D68.9), and adult respiratory distress
syndrome (ARDS) (582.82, J80) [11,12]. We did not
search for liver transplant-related codes because the CHR
does not have a liver transplant center. All transplants for
CHR residents are performed outside of the health region
at the University of Alberta in Edmonton, Alberta. A query
of the University of Alberta Liver Transplant database
revealed that no CHR residents were transplanted for
acetaminophen overdose during the study interval [32]. A
control group consisting of randomly-selected patients
without these codes, matched 1:1 for admission hospital,
was also identified. The inpatient medical records of this
cohort were reviewed by a trained internist with gastroen-
terology experience (YL), blinded to administrative data,
using a standardized data abstraction form.
The validity of the diagnoses of interest was assessed using
predefined criteria. Acetaminophen overdose was defined
as the ingestion of > 4 grams within a 24-hour period (the
maximum dosage recommended in the product mono-
graph) [8]. Smaller reported ingestions [8] and unquanti-
fiable overdoses (eg. large amounts of acetaminophen
reported unequivocally by the patient or family member)
were included as cases if hepatotoxicity occurred (see
below) and no alternative cause could be implicated or a
serum level >10 mg/L (66 umol/L) was found [30]. Aceta-
minophen hepatotoxicity was defined by an alanine ami-
notransferase (ALT) > 1,000 U/L [27-31]. ALF was defined
by encephalopathy and an international normalized ratio
(INR) > 1.5 [7,8].
Statistical methods
Data were analyzed using Stata 8.2 software (StataCorp,
College Station, TX). The generation of the diagnostic
algorithms was performed in a step-wise fashion. First, an
algorithm for acetaminophen overdose was generated in
the entire cohort. Subsequently, data from these pre-
sumed acetaminophen overdose cases was used to gener-
ate algorithms for hepatotoxicity and ALF. These
algorithms were derived using multivariate logistic regres-
sion analyses including the most predictive diagnostic
codes for these outcomes. Algorithms were compared
using areas under receiver operating characteristics curves
(c-statistics) and the non-parametric method of DeLong et
al [33]. The c-statistic ranges from 0 to 1.0, with 1.0 indi-
cating perfect prediction and 0.5 indicating prediction
due to chance alone. C-statistics between 0.7 and 0.8 are
generally considered acceptable, while those over 0.8 are
considered most desirable. We also calculated sensitivi-
ties, specificities, and positive (PPV) and negative predic-
tive values (NPV) for these algorithms, including exact
binomial confidence intervals (CI). Because the coding
system changed from ICD-9-CM to ICD-10 in fiscal year
2002, the impact of the study interval (1995–2001 vs.
2002–2004) on the performance of the algorithms was
assessed in sensitivity analyses. We also examined patient
gender, age (≤ versus > the median), and hospital of
admission (to account for different coders) as potential
predictors of coding accuracy.
The study protocol was approved by the Conjoint Health
Research Ethics Board at the University of Calgary.
Results
Diagnosis of acetaminophen overdose
Between fiscal years 1995 and 2004, a total of 1,776
patients met our criteria for potential acetaminophen
overdose. Of these, 92 patients were identified by the
administrative data as potential cases of acetaminophen
hepatotoxicity, and a random sample (n = 92) of the
remaining 1,684 patients was selected as controls. The
charts of 3 patients were missing, leaving 181 available for
data abstraction. The median age of the cohort was 39
years (range 15–84) and 68% were female. After detailed
chart review, acetaminophen overdose was confirmed in
139 (77%) of these patients. The remaining 42 patients
were admitted for miscellaneous overdoses (n = 28: sali-
cylates [n = 14], NSAIDs [n = 4], and other medications [n
= 10]), adverse effects of the therapeutic use of other med-
ications (n = 4), and unrelated diagnoses (n = 10). In 26
of these 42 cases (62%), non-specific codes (ie. poten-
tially coding for medications other than acetaminophen)
were recorded.
The operating characteristics of various coding algorithms
for the identification of acetaminophen overdose are
listed in Table 2. Based on the c-statistics, the optimal
algorithm included the principal diagnostic codes for
acetaminophen overdose (965.4,T39.1) in either the pri-
mary or secondary diagnosis fields. This algorithm would
detect 132 potential cases, including 125 of the 139BMC Health Services Research 2007, 7:159 http://www.biomedcentral.com/1472-6963/7/159
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patients with confirmed acetaminophen overdose (sensi-
tivity 90%; 95% CI 84–94%). The specificity, PPV, and
NPV for this algorithm were 83% (95% CI 69–93%), 95%
(89–98%), and 71% (57–83%), respectively. The operat-
ing characteristics were not affected by the diagnostic cod-
ing system used (Table 3) and were similar among cases
with and without hepatotoxicity as described below
(Table 4). Similarly, the c-statistic (0.87 [0.80–0.93]) was
not affected by the study interval (ie. 1995–2001: 0.86
[95% CI 0.78–0.94] vs. 2002–2004: 0.88 [0.78–0.97]; P =
0.77), patient age (P = 0.14) or gender (P = 0.33). How-
ever, if these codes were limited to the primary diagnosis
field (ie. secondary diagnoses excluded), the diagnostic
utility decreased substantially (c-statistic 0.72; 95% CI
0.67–0.77; P < 0.0005 vs. the algorithm including all diag-
nosis fields). Moreover, the c-statistic varied between the
3 hospitals included in the study (site 1 [n = 119]: 0.84
[95% CI 0.76–0.92] vs. site 2 [n = 32]: 0.98 [0.94–1.00]
vs. site 3 [n = 30]: 0.90 [0.81–0.98]; chi2 [2 df] = 11.46; P
= 0.003).
Diagnosis of acetaminophen hepatotoxicity
According to medical record review, 59 of the 132 patients
identified by the optimal acetaminophen overdose algo-
rithm developed hepatotoxicity. Table 5 illustrates the fre-
quency of various diagnostic codes consistent with liver
injury in these patients versus those not developing hepa-
totoxicity (n = 73, including 7 patients falsely identified as
cases of acetaminophen overdose). Codes for jaundice
and hepatorenal syndrome were not recorded in any
patient. The most discriminative codes were hepatic
necrosis (odds ratio [OR] 17.16; 95% CI 4.65–92.85),
toxic hepatitis (OR 7.85; 3.01–21.98), and hepatic
encephalopathy (OR 12.96; 1.67–575.6). A diagnostic
algorithm including at least one of these codes was highly
predictive of hepatotoxicity (OR 77.5; 95% CI 23.3–
257.5). The sensitivity, specificity, PPV, and NPV of this
algorithm were 93% (95% CI 84–98% [55/59 cases]),
85% (75–92% [62/73]), 83% (72–91% [55/66]), and
94% (85–98% [62/66]), respectively. These figures were
not affected by the diagnostic coding system used (Table
3). The corresponding c-statistic (0.89 [95% CI 0.84–
0.94]) was not affected by the study interval (P = 0.62),
patient age (P = 0.93), gender (P = 0.67), or admission
hospital (P  = 0.89). Moreover, if the algorithm was
applied to the entire study cohort of 181 patients (ie.
including non-acetaminophen overdose cases), the c-sta-
tistic did not change substantially (0.94; 95% CI 0.88–
0.99; P = 0.24 vs. the primary analysis).
Diagnosis of ALF
Of the 132 patients identified as having acetaminophen
overdose, 22 developed ALF. The frequencies with which
liver-related diagnostic codes were recorded in these
patients are listed in Table 6. The most discriminative
codes were hepatic encephalopathy (OR 75.46; 95% CI
8.73–3335) and necrosis (OR 9.15; 2.96–28.46). Toxic
hepatitis was recorded in fewer patients with ALF than
non-ALF cases (18% vs. 30%), but the difference was not
significant (P = 0.31). A diagnostic algorithm including at
least one of the codes for either hepatic encephalopathy or
necrosis was highly predictive of ALF (OR 58.8; 95% CI
12.5–276.0). The sensitivity, specificity, PPV, and NPV of
this algorithm were 91% (95% CI 71–99% [20/22 cases]),
85% (77–91% [94/110]), 56% (38–72% [20/36]), and
98% (93–100% [94/96]), respectively. These operating
characteristics were not affected by the diagnostic coding
system used (Table 3). The corresponding c-statistic (0.88
[95% CI 0.81–0.95]), was not affected by the study inter-
val (P = 0.18), patient age (P = 0.40), gender (P = 0.48),
admission hospital (P = 0.19), or inclusion of patients not
identified as overdose cases using the overdose algorithm
(P = 0.46). If use of the ALF algorithm was restricted to
patients identified as having acetaminophen hepatotoxic-
ity, the sensitivity, specificity, PPV, and NPV were 89%
(95% CI 67–97% [17/19 cases]), 63% (46–77% [25/40]),
53% (35–71% [17/32]), and 93% (76–99% [25/27]),
respectively.
Table 2: Operating characteristics of diagnostic coding algorithms for the identification of acetaminophen overdose
C-statistic (95% CI)
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* See Table 1.
† Non-specific codes (ie potentially including overdoses due to medications other than acetaminophen) excluded.
‡ P < 0.005 vs. the algorithm limited to specific codes.
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Table 3: Operating characteristics of the coding algorithms according to diagnostic coding system (ICD-9-CM vs. ICD-10) *
Outcome/
Coding System
Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI) C-statistic (95% CI)
Acetaminophen 
overdose
ICD-9-CM 91% (83–96%) (81/89) 81% (61–93%) (21/26) 94% (87–98%) (81/86) 72% (53–87%) (21/29) 0.86 (0.78–0.94)
ICD-10 88% (77–95%) (44/50) 88% (62–98%) (14/16) 96% (85–99%) (44/46) 70% (46–88%) (14/20) 0.88 (0.78–0.97)
Hepatotoxicity
ICD-9-CM 97% (86–100%) (36/37) 80% (66–90%) (39/49) 78% (64–89%) (36/46) 98% (87–100%) (39/40) 0.88 (0.82–0.95)
ICD-10 86% (65–97%) (19/22) 96% (79–100%) (23/24) 95% (75–100%) (19/20) 88% (70–98%) (23/26) 0.91 (0.83–0.99)
Acute liver failure
ICD-9-CM 85% (55–98%) (11/13) 85% (75–92%) (62/73) 50% (28–72%) (11/22) 97% (89–100%) (62/64) 0.85 (0.74–0.96)
ICD-10 100% (N/A) (9/9) 86% (71–95%) (32/37) 64% (35–87%) (9/14) 100% (NA) (32/32) 0.93 (0.88–0.99)
* None of the comparisons between the ICD-9-CM and ICD-10 coding systems are statistically significant (P > 0.05 for all).
CI, confidence interval; NPV, negative predictive value; NA, not applicable; PPV, positive predictive value.
Table 4: Operating characteristics of the acetaminophen overdose algorithm according to the development of hepatotoxicity
Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI) C-statistic (95% CI)
No hepatotoxicity (n = 112)
Overall 94% (86–98%) (66/70) 83% (69–93%) (35/42) 90% (81–96%) (66/73) 90% (76–97%) (35/39) 0.89 (0.82–0.95)
ICD-9-CM 94% (82–99%) (44/47) 81% (61–93%) (21/26) 90% (78–97%) (44/49) 88% (68–97%) (21/24) 0.87 (0.79–0.96)
ICD-10 96% (78–100%) (22/23) 88% (62–98%) (14/16) 92% (73–99%) (22/24) 93% (68–100%) (14/15) 0.92 (0.82–1.00)
Hepatotoxicity (n = 69) *
Overall 86% (75–93%) (59/69) N/A 100% (NA) (59/59) 0% (NA) (0/10) N/A
ICD-9-CM 88% (74–96%) (37/42) N/A 100% (NA) (37/37) 0% (NA) (0/5) N/A
ICD-10 81% (62–94%) (22/27) N/A 100% (NA) (22/22) 0% (NA) (0/5) N/A
* Hepatotoxicity as defined by the following diagnostic codes: hepatic necrosis (570, K71.1), toxic hepatitis (573.3, K71.2, K71.6, K71.9), and hepatic 
encephalopathy (572.2, K72.0, K72.9). Because hepatotoxicity cases had acetaminophen overdose by definition, the PPV of the overdose algorithm 
is 100% in these cases. For the same reason, the specificities and c-statistics cannot be calculated, and the NPVs are 0%.
CI, confidence interval; NPV, negative predictive value; NA, not applicable; PPV, positive predictive value.
Table 5: Frequency of liver-related diagnostic codes according to the development of hepatotoxicity *
Clinical Diagnosis (Codes) Hepatotoxicity (n = 59) No Hepatotoxicity (n = 73) Odds Ratio (95% CI) P-value
Hepatic necrosis (570, K71.1) 42.4% (25) 4.1% (3) 17.16 (4.65–92.85) < 0.0005
Toxic hepatitis (573.3, K71.2, K71.6, K71.9) 48.2% (29) 11.0% (8) 7.85 (3.01–21.98) < 0.0005
Hepatic encephalopathy (572.2, K72.0, K72.9) 15.3% (9) 1.4% (1) 12.96 (1.67–575.6) 0.005
Coagulopathy (286.7, D68.4, D68.9) 6.8% (4) 4.1% (3) 1.70 (0.27–12.02) 0.70
ARDS (582.82, J80) 1.7% (1) 0% -- 0.45
* In patients identified by the acetaminophen overdose coding algorithm including codes 965.4 and T39.1. Codes for jaundice and hepatorenal 
syndrome were not recorded in any patient.
ARDS, adult respiratory distress syndrome. CI, confidence interval.
Table 6: Frequency of liver-related diagnostic codes according to the development of acute liver failure (ALF) *
Clinical Diagnosis (Codes) ALF (n = 22) No ALF (n = 110) Odds Ratio (95% CI) P-value
Hepatic necrosis (570, K71.1) 59.1% (13) 13.6% (15) 9.15 (2.96–28.46) < 0.0005
Toxic hepatitis (573.3, K71.2, K71.6, K71.9) 18.2% (4) 30.0% (33) 0.52 (0.12–1.75) 0.31
Hepatic encephalopathy (572.2, K72.0, K72.9) 40.9% (9) 0.9% (1) 75.46 (8.73–3335) < 0.0005
Coagulopathy (286.7, D68.4, D68.9) 9.1% (2) 4.6% (5) 2.10 (0.19–13.88) 0.33
ARDS (582.82, J80) 4.6% (1) 0% -- 0.17
* In patients identified by the acetaminophen overdose coding algorithm including codes 965.4 and T39.1. Codes for jaundice and hepatorenal 
syndrome were not recorded in any patient.
ARDS, adult respiratory distress syndrome. CI, confidence interval.BMC Health Services Research 2007, 7:159 http://www.biomedcentral.com/1472-6963/7/159
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Discussion
To our knowledge, this is the first study to systematically
evaluate the diagnostic accuracy of administrative data for
the identification of patients with acetaminophen over-
dose and liver-related complications. Using a population-
based, hospitalization database, we determined that the
principal diagnostic codes for acetaminophen overdose
(ICD-9-CM, 965.4; ICD-10, T39.1) had the optimal oper-
ating characteristics for case identification. This algorithm
was highly sensitive (90%) and specific (83%), thus, the
corresponding c-statistic was excellent (0.87). Moreover,
the PPV, which reflects the likelihood that an individual
truly has the disease for which the administrative data are
considered a surrogate, was very high (95%). This algo-
rithm proved much more accurate than two other algo-
rithms which were more sensitive (96–100%), but lacked
specificity (0–55%). For example, the non-specific algo-
rithm used for the initial selection of the study cohort
identified 181 potential cases, of which only 139 had
acetaminophen overdose (PPV, 77%). Of the 42 false pos-
itive cases, approximately three-quarters had overdosed or
had toxic effects of other medications, frequently sali-
cylates or NSAIDS. Many of these patients were falsely
identified by non-specific codes including external causes
of injury codes ('E codes'). These codes are frequently used
to define the intent of an overdose (eg. intentional, unin-
tentional, homicidal) [34,35] and some include over-
doses due to other nonopioid analgesics, antipyretics and
antirheumatics (Table 1). Based on these findings, we
would advise against using these non-specific codes for
the identification of patients with acetaminophen over-
dose.
In light of our findings, the results of previous and future
investigations of acetaminophen overdose should be con-
sidered. In the only other study which utilized medical
record review to validate acetaminophen overdose diag-
noses made using administrative data,[31] the PPV of our
optimal algorithm (965.4, T39.1) was lower (78%) than
observed in our study (95%). Although differences in the
study populations and coding accuracy between centers
may be involved, we suspect that this difference reflects
the inclusion of only patients with single acute ingestions
in the latter study,[31] whereas we included patients with
multiple time-point ingestions (eg. unintentional over-
doses). These patients should not be ignored since they
have been linked with a higher frequency of hepatotoxic-
ity and ALF [8,30,36].
In another epidemiologic study from Scotland,[10] Bate-
man et al. used the same codes to report annual hospital-
ization rates of 91–120 per 100,000 population between
1990 and 1999. Based on the 90% sensitivity that we
observed for this algorithm, these figures would appear to
underestimate the true incidence of acetaminophen over-
dose by approximately 10%. Although not a major dis-
crepancy, particularly for the examination of temporal
trends, this factor should be considered in other contexts
such as studies of health resource utilization and the cost-
effectiveness of preventive measures. In the Canadian
study by Prior et al. [11] and in an analysis of U.S. hospi-
talization rates by investigators at the Food and Drug
Administration (FDA), cases were identified using ICD-9-
CM codes 965.4 and E850.4. Based on our findings, one
might expect the use of the latter E code to have overesti-
mated hospitalization rates. Interestingly, however, our
data suggest that the isolated use of this E code does not
decrease the accuracy of the algorithm because the princi-
pal code 965.4 was recorded in all patients with E850.4 in
our database (data not shown).
The algorithms that we have developed hold promise for
use in future studies in this field. Specifically, epidemio-
logic studies evaluating temporal trends and risk factors
for acetaminophen overdose will be facilitated. For exam-
ple, changes in labeling requirements for acetaminophen-
containing products were recently recommended (but not
acted upon) by an FDA committee in an attempt to reduce
the frequency of unintentional overdoses [9,37]. Our
algorithm will assist in determining the effectiveness of
such recommendations, not only in terms of the number
of acetaminophen overdoses, but also the frequency of
severe cases associated with hepatotoxicity. Studies from
the U.K. have suggested that package size restrictions have
reduced the number of severe cases, but these studies are
limited by the analysis of data predominantly from trans-
plant centers [14-17]. The algorithms that we have derived
can be used with population-based, administrative data-
sets to overcome the referral bias inherent in the afore-
mentioned studies. Other potential applications include
their use to monitor changes in outcomes of acetami-
nophen overdose as new therapies are developed, and the
assessment of controversial risk factors including alcohol
abuse and underlying liver disease on rates of hepatotox-
icity.
In addition to identifying overdose cases, we aimed to
develop accurate coding algorithms for acetaminophen-
related liver injury. Although hepatotoxicity occurs in a
small minority of cases, acetaminophen overdose is the
most common cause of ALF,[7,8] largely due to the mag-
nitude of this problem. According to FDA estimates,
nearly 500 deaths attributable to acetaminophen over-
dose occur annually in the U.S. alone [13]. For the identi-
fication of acetaminophen-related hepatotoxicity, defined
as an ALT > 1,000 U/L, an algorithm including codes for
hepatic necrosis, toxic hepatitis, and hepatic encephalop-
athy (Table 3) was highly predictive. Specifically, the sen-
sitivity, specificity, and c-statistic of this algorithm were
93%, 85%, and 0.89, respectively. Similar figures wereBMC Health Services Research 2007, 7:159 http://www.biomedcentral.com/1472-6963/7/159
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obtained for an ALF algorithm including codes for hepatic
necrosis and encephalopathy (Table 5) (sensitivity 91%,
specificity 85%, c-statistic 0.88). Although the NPVs of
these algorithms were both very high (94–98%), the PPV
of the ALF algorithm was lower (56% vs. 83% for the
hepatotoxicity algorithm) likely due to the infrequent
occurrence of this severe complication. This algorithm
cannot accurately identify the subset of hepatotoxicity
patients who progress to ALF, presumably due to the over-
lapping codes used in these algorithms (ie. both include
hepatic necrosis and encephalopathy, while the hepato-
toxicity algorithm also includes toxic hepatitis). There-
fore, the ALF algorithm is most applicable when used in
an entire overdose cohort. Interestingly, diagnostic codes
for other liver-related complications were either not dis-
criminative (eg. coagulopathy) or not recorded (eg. jaun-
dice and hepatorenal syndrome), arguing against their use
for case identification.
In addition to developing these coding algorithms, we
performed sensitivity analyses to examine the impact of
various patient and system-related factors on their accu-
racy. Although acetaminophen overdose is more common
in younger individuals and females,[10,13] age and gen-
der were not significant in these analyses. Similarly,
despite a switch from the ICD-9-CM to ICD-10 coding sys-
tem in 2002, the study interval did not affect the operating
characteristics. On the contrary, the accuracy of the over-
dose algorithm varied between three hospitals, although
the c-statistics were very good at all facilities (0.84, 0.90
and 0.98, respectively). Nevertheless, the observed differ-
ences reinforce the necessity of studies externally validat-
ing our findings. Finally, we found that the
acetaminophen overdose algorithm was much less sensi-
tive if the appropriate codes were restricted to the primary
diagnosis field only. Many of the cases that would have
been missed by such an approach had liver-related codes
as the main indication for hospitalization.
Our study has several limitations that must be acknowl-
edged. First, we examined a single hospitalization data-
base from a Canadian health region. Since we cannot
exclude a regional bias in the coding of administrative
data, our findings must be validated using alternative
databases (eg. outpatient and emergency databases) in
different settings. Second, our chart validation used as the
reference standard may be subject to misclassification
bias. We minimized this by using a structured data collec-
tion instrument and a reviewer of medical records that
was blinded to administrative data. Moreover, this
reviewer is a trained internist with experience managing
patients with acetaminophen overdose and liver disease
of all etiologies. Finally, patients with acetaminophen-
related hepatotoxicity were over-represented in our study
cohort due to our method of patient selection (ie. inten-
tional over-selection due to the relative rarity of this out-
come). This factor may have overestimated the PPVs for
the liver-related outcomes due to the higher than normal
prevalence of these complications in the cohort. Never-
theless, the other measures of diagnostic accuracy that we
considered, including the c-statistic, are not affected by
disease prevalence.
Conclusion
In summary, we have validated a hospitalization database
for the identification of patients with acetaminophen
overdose and associated hepatotoxicity. Although our
findings must be validated, this is an important prerequi-
site for the use of administrative databases in future epide-
miologic studies of this common and potentially deadly
condition.
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